Bleomycin	NN
in	IN
the	DT
setting	NN
of	IN
lung	NN
fibrosis	NN
induction	NN
:	:
From	IN
biological	JJ
mechanisms	NNS
to	TO
counteractions	NNS
.	.

UNASSIGNED	NNP
:	:
Bleomycin	NN
(	(
BLM	NN
)	)
is	VBZ
a	DT
drug	NN
used	VBN
to	TO
treat	VB
different	JJ
types	NNS
of	IN
neoplasms	NNS
.	.

BLM	NNP
's	POS
most	JJS
severe	JJ
adverse	JJ
effect	NN
is	VBZ
lung	NN
toxicity	NN
,	,
which	WDT
induces	VBZ
remodeling	NN
of	IN
lung	NN
architecture	NN
and	CC
loss	NN
of	IN
pulmonary	JJ
function	NN
,	,
rapidly	RB
leading	VBG
to	TO
death	NN
.	.

While	IN
its	PRP$
clinical	JJ
role	NN
as	IN
an	DT
anticancer	JJ
agent	NN
is	VBZ
limited	VBN
,	,
its	PRP$
use	NN
in	IN
experimental	JJ
settings	NNS
is	VBZ
widespread	JJ
since	IN
BLM	NNP
is	VBZ
one	CD
of	IN
the	DT
most	RBS
widely	RB
used	VBN
drugs	NNS
for	IN
inducing	VBG
lung	NN
fibrosis	NN
in	IN
animals	NNS
,	,
due	JJ
to	TO
its	PRP$
ability	NN
to	TO
provoke	VB
a	DT
histologic	JJ
lung	NN
pattern	NN
similar	JJ
to	TO
that	DT
described	VBN
in	IN
patients	NNS
undergoing	VBG
chemotherapy	NN
.	.

This	DT
pattern	NN
is	VBZ
characterized	VBN
by	IN
patchy	JJ
parenchymal	JJ
inflammation	NN
,	,
epithelial	JJ
cell	NN
injury	NN
with	IN
reactive	JJ
hyperplasia	NN
,	,
epithelial-mesenchymal	JJ
transition	NN
,	,
activation	NN
and	CC
differentiation	NN
of	IN
fibroblasts	NNS
to	TO
myofibroblasts	NNS
,	,
basement	NN
membrane	NN
and	CC
alveolar	JJ
epithelium	NN
injuries	NNS
.	.

Several	JJ
studies	NNS
have	VBP
demonstrated	VBN
that	IN
BLM	NNP
damage	NN
is	VBZ
mediated	VBN
by	IN
DNA	NN
strand	NN
scission	NN
producing	VBG
single	JJ
-	:
or	CC
double-strand	JJ
breaks	NNS
that	WDT
lead	VBP
to	TO
increased	VBN
production	NN
of	IN
free	JJ
radicals	NNS
.	.

Up	IN
to	TO
now	RB
,	,
the	DT
mechanisms	NNS
involved	VBN
in	IN
the	DT
development	NN
of	IN
pulmonary	JJ
fibrosis	NN
have	VBP
not	RB
been	VBN
fully	RB
understood	VBN
;	:
several	JJ
studies	NNS
have	VBP
analyzed	VBN
various	JJ
potential	JJ
biological	JJ
molecular	JJ
factors	NNS
,	,
such	JJ
as	IN
transforming-growth-factor-beta-1	NN
,	,
tumor-necrosis-factor-alpha	NN
,	,
components	NNS
of	IN
the	DT
extracellular	JJ
matrix	NN
,	,
chaperones	NNS
,	,
interleukins	NNS
and	CC
chemokines	NNS
.	.

The	DT
aim	NN
of	IN
this	DT
paper	NN
is	VBZ
to	TO
review	VB
the	DT
specific	JJ
characteristics	NNS
of	IN
BLM-induced	JJ
lung	NN
fibrosis	NN
in	IN
different	JJ
animal	NN
models	NNS
and	CC
to	TO
summarize	VB
modalities	NNS
and	CC
timing	NN
of	IN
in	FW
vivo	FW
drug	NN
administration	NN
.	.

Understanding	VBG
the	DT
mechanisms	NNS
of	IN
BLM-induced	JJ
lung	NN
fibrosis	NN
and	CC
of	IN
commonly	RB
used	VBN
therapies	NNS
for	IN
counteracting	VBG
fibrosis	NN
provides	VBZ
an	DT
opportunity	NN
for	IN
translating	VBG
potential	JJ
molecular	JJ
targets	NNS
from	IN
animal	NN
models	NNS
to	TO
the	DT
clinical	JJ
arena	NN
.	.

